Rank #1611STRO

Sutro Biopharma, Inc.

$19.56

12.22% (Daily)

Market Cap

$320.54M

Revenue

$105.65M

Rank by MCap

#1611

Sector

Healthcare

Industry

Biotechnology

CEO

Ms. Jane Chung R.Ph.

Headquarters

South San Francisco, CA

Employees

178

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. operates as a oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF; and site-specific conjugation platform, XpressCF+. Its lead product candidate includes STRO-004, a tissue factor (TF) targeting ADC for the treatment of TF-expressing solid tumors, including cervical, lung, and breast cancer. The company also develops VAX-24 and Vax-31 p...